Hypertension Clinical Trials in Phoenix

Showing 221-227 of 227 trials

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

NCT00345774

This study is being conducted to see if PRX-08066 can lower pulmonary artery pressures in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease.

Pulmonary HypertensionChronic Obstructive Pulmonary Disease

Epix Pharmaceuticals, Inc.72 participantsStarted Jun 2006

Anniston, Alabama, United States • Phoenix, Arizona, United States • Sacramento, California, United States +16 more locations

WITHDRAWNPhase 2< 1 mile

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

NCT00323024

The purpose of this study is to determine the safety and maximum tolerated dose of inhaled NX1011 for the treatment of pulmonary arterial hypertension (PAH).

Pulmonary Hypertension

NITROX, LLC72 participantsStarted Sep 2006

Phoenix, Arizona, United States • La Jolla, California, United States • Newark, Delaware, United States +3 more locations

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

Hypertension Trials in Other Cities

Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension

Other Conditions in Phoenix